Two Sigma Securities’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Two Sigma Securities's MRNA Position: Q3 2026 in Review
Two Sigma Securities opened a new position in Moderna (MRNA) in Q3 2026: 8,606 shares worth $1.66M. The stake represents 0.13% of the portfolio and ranks #168 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in MRNA as recently as Q3 2023.
Two Sigma Securities first reported a position in MRNA in Q4 2020 and has held it in 13 quarters since. The position peaked at $7.74M in Q1 2023. 1,053 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Two Sigma Securities held 8,606 shares of Moderna worth $1.66M as of Q3 2026.
- Moderna was a new Two Sigma Securities position in Q3 2026.
- Moderna made up 0.13% of Two Sigma Securities's portfolio in Q3 2026, its #168 holding.
- Two Sigma Securities first reported a position in Moderna in Q4 2020 and has held it in 13 quarters since.
- Two Sigma Securities's Moderna position peaked at $7.74M in Q1 2023.
- 1,053 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Two Sigma Securities's 13F filing for Q3 2026, filed 16 Nov 2026.